Anthropic is an AI-driven research company that focuses on increasing the safety of AI systems. Its research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability. The initial product from the company is Claude, an AI helper for tasks of any size.Anthropic envisions a future where AI systems are developed, emphasizing safety, transparency, and alignment with human values. The company seeks to contribute to creating AI technologies that enhance human well-being and are trustworthy and reliable.
Carbon Crusher is a road tech company that repairs roads in a carbon-negative way. We work with public and private road owners. Carbon Crusher replaces heavy oil with carbon-binding biopolymers and reuse old road materials with our crusher. The result is durable, recycled, and sustainable roads. We are committed to solving climate change and making a positive impact on our planet. Our goal is to change the negative trajectory the planet is on with sound values and innovative solutions. As Margaret Mead once said, “Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has”.
Charm Industrial has developed a novel pathway for carbon sequestration: putting oil back underground in the form of bio-oil. The process converts agricultural residue to bio-oil, then injects the bio-oil into deep geological formations for permanent storage. After winning carbon removal contracts from Stripe, Shopify and Microsoft in 2020, Charm Industrial began rapidly scaling fulfillment. At scale, Charm Industrial plans to gasify bio-oil to produce industrial syngas. Charm's engineering team is based in San Francisco, with operations in Louisiana, Kansas and Oklahoma.
Clerkenwell Health is an innovative mental health company offering clinical research support services and psychedelic-assisted therapies. By providing independent psychedelic-specialist CRO services, Clerkenwell will accelerate the adoption of these treatments across Europe. The team are passionate about putting patients at the centre of clinical trial design and delivering gold standard therapy protocols.